1. AB0396 Tocilizumab i.v. effectiveness in ra patients is independent of smoking status. (15th June 2017) Authors: Specker, C; Kellner, H; Kästner, P; Volberg, C; Braunewell, V; Schwarze, I; Aringer, M; Sieburg, M; Hofmann, MW; Flacke, JP; Tony, H-P; Fliedner, G Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate. Issue 11 (14th October 2008) Authors: Owczarczyk, K; Hellmann, M; Fliedner, G; Röhrs, T; Maizus, K; Passon, D; Hallek, M; Rubbert, A Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 11(2008) Page Start: 1648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0193 Ra patients with inflammatory anemia benefit from increased hemoglobin and decreased fatigue under tocilizumab therapy. (15th June 2017) Authors: Specker, C; Kellner, H; Kästner, P; Volberg, C; Braunewell, V; Schwarze, I; Aringer, M; Sieburg, M; Hofmann, MW; Flacke, JP; Tony, H-P; Fliedner, G Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 844 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗